GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genesystem Co Ltd (XKRX:363250) » Definitions » Purchase Of Investment

Genesystem Co (XKRX:363250) Purchase Of Investment : ₩-13,786.5 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genesystem Co Purchase Of Investment?

Genesystem Co's purchase of investment for the three months ended in Mar. 2024 was ₩-2,426.0 Mil. It means Genesystem Co spent ₩2,426.0 Mil on purchasing investments. Genesystem Co's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-13,786.5 Mil.

Compared with last quarter (₩1,090.4 Mil in Dec. 2023 ), Genesystem Co spent more money on purchasing investments in Mar. 2024 (₩-2,426.0 Mil).


Genesystem Co Purchase Of Investment Historical Data

The historical data trend for Genesystem Co's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesystem Co Purchase Of Investment Chart

Genesystem Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
- - -15,120.00 -15,860.00 -17,104.82

Genesystem Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5,744.35 -2,150.00 -10,300.87 1,090.40 -2,426.04

Genesystem Co Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-13,786.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genesystem Co Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Genesystem Co's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Genesystem Co (XKRX:363250) Business Description

Traded in Other Exchanges
N/A
Address
200-9, Techno 2-ro, Yuseong-gu, Daejeon, KOR, 34028
Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.

Genesystem Co (XKRX:363250) Headlines

No Headlines